Stock listing

Euronext:ALOPM Oncodesign Precision Medicine S.A. Action

Home listing (Euronext) of Oncodesign Precision Medicine S.A.

Follow Oncodesign Precision Medicine S.A. into a list and get an email when it puts out news.

Share price · EURONEXT:ALOPM

€0.26 EUR 0.00 (0.0%)

Close on Nov 2, 2026

Past year -48.4% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
€0.26 – €0.26 EURNov 2, 2026
Volume
131 sharesNov 2, 2026
Market cap
€4.96M EURAt the close on Nov 2, 2026 · price × 19.07M shares outstanding
52-week range
€0.20 – €0.92 EURLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
€6,621 EURMedian day 14,076 shares · 1 day with no trades · last 3 months, Aug 3, 2026 – Nov 2, 2026
Oncodesign Precision Medicine S.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALOPM · Home€0.26 EUR0.00 (0.0%)131€0.26€0.26€0.26€0.26Close on Nov 2, 2026
Frankfurt:ZR8€0.228 EUR+0.007 (+3.2%)—€0.216€0.228€0.216€0.221Close on Oct 30, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · EURONEXT:ALOPM · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.260.000.0%€0.26€0.26€0.26131
€0.26+0.02+8.3%€0.24€0.26€0.2423,390
€0.24-0.007-2.8%€0.24€0.25€0.23617,900
€0.247-0.003-1.2%€0.249€0.25€0.24727,785
€0.25-0.006-2.3%€0.255€0.258€0.2362,996
€0.256-0.034-11.7%€0.29€0.29€0.25628,366
€0.29-0.037-11.3%€0.328€0.328€0.2947,225
€0.327+0.007+2.2%€0.33€0.33€0.30421,229
€0.32-0.01-3.0%€0.329€0.329€0.321,043
€0.33+0.02+6.5%€0.32€0.33€0.3191,552
€0.31-0.031-9.1%€0.34€0.348€0.3110,432
€0.341+0.021+6.6%€0.331€0.341€0.333,400
€0.32-0.03-8.6%€0.349€0.349€0.3225,102
€0.35+0.012+3.6%€0.33€0.35€0.3317,900
€0.338-0.011-3.2%€0.322€0.35€0.32233,730
€0.349+0.019+5.8%€0.32€0.35€0.3232,471
€0.33-0.025-7.0%€0.355€0.356€0.3344,535
€0.355+0.022+6.6%€0.36€0.37€0.3431,522
€0.3330.000.0%€0.334€0.35€0.33312,118
€0.333-0.047-12.4%€0.38€0.38€0.33314,966
€0.380.000.0%€0.38€0.385€0.380
€0.38+0.001+0.3%€0.38€0.385€0.387,964
€0.379-0.004-1.0%€0.379€0.38€0.3619,469
€0.383+0.013+3.5%€0.36€0.383€0.3626,405
€0.37+0.024+6.9%€0.36€0.37€0.33616,516
€0.346-0.02-5.5%€0.35€0.35€0.31514,111
€0.366+0.056+18.1%€0.279€0.369€0.279215,448
€0.31+0.054+21.1%€0.271€0.31€0.2645,065
€0.256+0.012+4.9%€0.258€0.31€0.2584,450
€0.244+0.014+6.1%€0.231€0.246€0.2315,593
€0.23-0.016-6.5%€0.245€0.245€0.23845
€0.246+0.009+3.8%€0.237€0.246€0.2321,826
€0.237+0.017+7.7%€0.21€0.237€0.2113,335
€0.22+0.02+10.0%€0.211€0.23€0.2031,615
€0.20-0.015-7.0%€0.216€0.224€0.206,177
€0.215-0.016-6.9%€0.229€0.229€0.2151,801
€0.231-0.008-3.3%€0.238€0.239€0.21549,088
€0.239+0.019+8.6%€0.234€0.257€0.23426,579
€0.22-0.025-10.2%€0.245€0.245€0.2229,941
€0.245+0.005+2.1%€0.23€0.245€0.2249,802
€0.24-0.005-2.0%€0.243€0.244€0.2316,012
€0.245+0.02+8.9%€0.231€0.245€0.239,255
€0.225-0.025-10.0%€0.25€0.25€0.2254,379
€0.25+0.001+0.4%€0.257€0.258€0.258,486
€0.249-0.001-0.4%€0.25€0.258€0.23229,582
€0.25-0.029-10.4%€0.27€0.278€0.2588,910
€0.279-0.002-0.7%€0.28€0.282€0.2660,489
€0.281-0.036-11.4%€0.317€0.317€0.28165,301
€0.317-0.002-0.6%€0.319€0.319€0.3061,429
€0.319-0.003-0.9%€0.319€0.319€0.319201
€0.322+0.001+0.3%€0.31€0.327€0.30217,261
€0.321-0.005-1.5%€0.32€0.326€0.32908
€0.326+0.01+3.2%€0.321€0.326€0.324,730
€0.316+0.002+0.6%€0.316€0.325€0.3151,470
€0.314-0.011-3.4%€0.304€0.327€0.30414,041
€0.325+0.005+1.6%€0.32€0.327€0.323,087
€0.32-0.006-1.8%€0.326€0.327€0.322,083
€0.3260.000.0%€0.327€0.327€0.3261,035
€0.326-0.001-0.3%€0.328€0.328€0.326841
€0.327+0.007+2.2%€0.32€0.328€0.3126,700
€0.32-0.002-0.6%€0.32€0.328€0.323,828
€0.322+0.001+0.3%€0.322€0.328€0.3221,179
€0.321-0.019-5.6%€0.318€0.321€0.3187,015
€0.34+0.029+9.3%€0.313€0.341€0.3137,458
€0.311-0.001-0.3%€0.311€0.311€0.31122
€0.312-0.01-3.1%€0.319€0.32€0.312269
Ticker
Euronext:ALOPM
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

OPM Announces Its 2026 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position

Oct 22, 2026

Closed €0.327 (+2.2%) on Oct 22, 2026

OPM Achieved Several Major Scientific and Regulatory Milestones as Part of the LARKIN Program, Supported With Funding By The Michael J. Fox Foundation for Parkinson's Research (MJFF)

Oct 7, 2026

Closed €0.355 (+6.6%) on Oct 8, 2026

OPM Announces Its 2025 Annual Results and Provides an Update on Its Clinical Developments

Apr 30, 2026

Closed €0.458 (+4.1%) on May 4, 2026

Oncodesign Precision Medicine Receives Support from The Michael J. Fox Foundation to Advance Development of LRRK2 Inhibitor OPM-201 for Parkinson’s Disease

Mar 3, 2026

Closed €0.664 (+44.3%) on Mar 4, 2026

Oncodesign Precision Medicine and Ksilink Join Forces to Test the Nanocyclix® Chemical Library in Cell Models Derived From Patients With Serious Central Nervous System Diseases

Jan 8, 2026

Closed €0.84 (+64.7%) on Jan 9, 2026

Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics

Dec 29, 2025

Closed €0.409 (+7.3%) on Dec 30, 2025

OPM Obtains Development Grants From the Bourgogne Franche-Comté Region

Oct 14, 2025

OPM Publishes Its 2025 Half-Yearly Report

Oct 9, 2025

OPM Integrated Into the LRRK2 Investigative Therapeutics Exchange Program From the Michael J. Fox Foundation for Parkinson’s Research

Sep 25, 2025

Oncodesign Precision Medicine Announces Equity Financing of up to 5 Million Euros

Apr 17, 2025

All Oncodesign Precision Medicine S.A. news

Decks

Oncodesign Precision Medicine S.A. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
7 in the last 12 months · 21 in all · newest Oct 22, 2026 · oldest 2024
Decks
1 deck · latest Dec 5, 2023

Where Oncodesign Precision Medicine S.A. is listed

ListingExchangeCountryCurrency
Euronext:ALOPM · Home listing · This pageEuronextFranceEUR
Lang & Schwarz:A3DVNMLang & SchwarzGermanyEUR
LS Exchange:A3DVNMLS ExchangeGermanyEUR
Frankfurt:ZR8FrankfurtGermanyEUR
Stuttgart:ZR8StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Oncodesign Precision Medicine S.A.